rho kinase
Showing 26 - 50 of 2,065
Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)
Not yet recruiting
- Chronic Graft Versus Host Disease
-
Atlanta, GeorgiaNorthside Hospital
Sep 21, 2023
Retinitis Pigmentosa Trial in Pittsburgh, Paris (Ophthalmic examinations, Mobility Test)
Active, not recruiting
- Retinitis Pigmentosa
- Ophthalmic examinations
- Mobility Test
-
Pittsburgh, Pennsylvania
- +1 more
Apr 19, 2022
Retinopathy of Prematurity Trial in Kitakyushu, Ube, Fukuoka (Ripasudil ophthalmic solution 0.4%)
Recruiting
- Retinopathy of Prematurity
- Ripasudil ophthalmic solution 0.4%
-
Kitakyushu, Fukuoka, Japan
- +2 more
Apr 13, 2021
Immune Cell Response to Stimuli
Recruiting
- Inflammation
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Jan 25, 2023
Low Bone Density Trial in Toronto (Opportunistic screening for low BMD)
Not yet recruiting
- Low Bone Density
- Opportunistic screening for low BMD
-
Toronto, Ontario, Canada
- +1 more
Jul 13, 2022
Diabetes Trial in Istanbul (difficult laryngoscopy)
Completed
- Diabetes Mellitus
- difficult laryngoscopy
-
Istanbul, Bagcilar, Turkeyİstanbul Bagcilar Egitim ve arastirma hastanesi
Sep 2, 2021
Primary Cardiovascular Events Using the Multimarker Approach
Completed
- Cardiovascular Diseases
- +4 more
- measurement of multiple biomarkers
- (no location specified)
Jan 19, 2023
Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- Nebivolol Ophthalmic Suspension 1 Percent
- +3 more
-
Newport Beach, CaliforniaSite 0012
Jul 18, 2022
Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)
Active, not recruiting
- Neurofibromatosis 1
- Neurofibroma Plexiform
-
Shanghai, China
- +1 more
Jan 13, 2023
Primary Open-Angle Glaucoma Trial in Izmir, Manisa (GlaucoT Glaucoma Treatment Device)
Recruiting
- Primary Open-Angle Glaucoma
- GlaucoT Glaucoma Treatment Device
-
İzmir, Turkey
- +1 more
Mar 19, 2022
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +170 more
Jan 30, 2023
Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))
Not yet recruiting
- Lung Cancer
- Non Small Cell Lung Cancer
- Amivantamab 1050mg
- +2 more
-
Aurora, Colorado
- +2 more
Apr 25, 2023
Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in
Not yet recruiting
- Liver Transplant; Complications
- +3 more
- multi-kinase inhibitors in combination with bevacizumab
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023
Peripheral Arterial Disease Trial in Hong Kong (Active pedal plantarflexion (APP) test)
Recruiting
- Peripheral Arterial Disease
- Active pedal plantarflexion (APP) test
-
Hong Kong, Shatin, Hong KongPrince of Wales Hospital
Oct 13, 2022
Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- combination therapy with no MEKi
- +3 more
- (no location specified)
Nov 29, 2022
Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))
Recruiting
- Locally Advanced Solid Tumors
- +3 more
- Oral repotrectinib (TPX-0005)
-
Los Angeles, California
- +27 more
Aug 9, 2022
Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)
Not yet recruiting
- Lung Cancer
- Non-small Cell Lung Cancer
- Lorlatinib
- +2 more
- (no location specified)
Jul 7, 2023
Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Tianjin (NTQ2494 tablet)
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia (AML)
- NTQ2494 tablet
-
Tianjin, Tianjin, ChinaHematology Hospital of the Chinese Academy of Medical Sciences
Sep 17, 2023
Spinal Cord Injuries Trial in Iowa City (Low-frequency Exercise, High-frequency Exercise)
Recruiting
- Spinal Cord Injuries
- Low-frequency Exercise
- High-frequency Exercise
-
Iowa City, IowaUniversity of Iowa
Apr 5, 2022
Psoriasis Vulgaris Trial in San Francisco (deucravacitinib)
Not yet recruiting
- Psoriasis Vulgaris
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 4, 2023
Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)
Not yet recruiting
- Hepatocellular Carcinoma
- Atezolizumab and Bevacizumab
- Y90 + TKI
-
Chicago, IllinoisNorthwestern University
Nov 11, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)
Suspended
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome With Excess Blasts-2
-
Adelaide, Australia
- +193 more
Jan 5, 2023
Cancer Trial in Changsha (Protein Kinase Inhibitor)
Recruiting
- Cancer
- Protein Kinase Inhibitor
-
Changsha, Hunan, ChinaCentral South University
Jun 23, 2022
Chemo Induced Peripheral Neuropathy Trial (Omeprazole)
Not yet recruiting
- Chemotherapy Induced Peripheral Neuropathy
- (no location specified)
Jan 10, 2023